LABORATORY RESEARCH MicroRNA-205 Signaling Regulates Mammary Stem Cell Fate and Tumorigenesis Knockdown of microRNA-205 in mammary epithelial cells promoted epithelial-mesenchymal transition, disrupted epithelial cell polarity, and enhanced symmetric division to expand the stem cell population. [J Clin Invest] Full Article CXCL12-γ in Primary Tumors Drives Breast Cancer Metastasis To investigate the effects of chemokine C-X-C motif chemokine ligand 12 (CXCL12) isoforms on tumor growth and metastasis, researchers used a mouse xenograft model of metastatic human breast cancer combining CXCR4+ breast cancer cells and mammary fibroblasts secreting an isoform of CXCL12. [Oncogene] Abstract Mammary Glands Exhibit Molecular Laterality and Undergo Left-Right Asymmetric Ductal Epithelial Growth in MMTV-cNeu Mice Scientists showed that despite their morphologic symmetry, left versus right mammary glands in wild-type mice have baseline differences in gene expression that are L-R independently regulated during pubertal development, including genes that regulate luminal progenitor cell renewal, luminal cell differentiation, mammary tumorigenesis, tamoxifen sensitivity and chemotherapeutic resistance. [Oncogene] Abstract A Genomic Analysis of Mouse Models of Breast Cancer Reveals Molecular Features of Mouse Models and Relationships to Human Breast Cancer The degree to which mouse models model human breast cancer and are reflective of the human heterogeneity has yet to be demonstrated with gene expression studies on a large scale. To this end, researchers have built a database consisting of 1,172 mouse mammary tumor samples from 26 different major oncogenic mouse mammary tumor models. [Breast Cancer Res] Full Article | Press Release Mesenchymal Precursor Cells Maintain the Differentiation and Proliferation Potentials of Breast Epithelial Cells Investigators isolated and characterized human breast epithelial and mesenchymal precursors from reduction mammoplasty tissue and tagged them with lentiviral vectors. [Breast Cancer Res] Abstract | Full Article Obatoclax Analog SC-2001 Inhibits STAT3 Phosphorylation through Enhancing SHP-1 Expression and Induces Apoptosis in Human Breast Cancer Cells Researchers examined the efficacy and drug mechanism of an obatoclax analog SC-2001, a novel STAT3 inhibitor, in human breast cancer cells. STAT3-regulated proteins, including Mcl-1, survivin, and cyclin D1, were repressed by SC-2001. [Breast Cancer Res Treat] Abstract Phenotypic Plasticity in Normal Breast Derived Epithelial Cells Explant culture was utilized to isolate cells from pieces of breast tissue. Selective media and trypsinization were employed to select either epithelial cells or stromal cells. The primary, non-transformed epithelial cells were characterized by immunohistochemistry, flow cytometry, and in vitro cell culture. [BMC Cell Biol] Abstract | Full Article Age-Related Dysfunction in Mechanotransduction Impairs Differentiation of Human Mammary Epithelial Progenitors Multipotent progenitors from women aged <30 years were exposed to a physiologically relevant range of matrix elastic modulus (stiffness). Increased stiffness causes a differentiation bias towards myoepithelial cells while reducing production of luminal cells and progenitor maintenance. [Cell Rep] Abstract | Full Article | Graphical Abstract | Press Release CLINICAL RESEARCH Final Report of the Phase I/II Clinical Trial of the E75 (nelipepimut-S) Vaccine with Booster Inoculations to Prevent Disease Recurrence in High-Risk Breast Cancer Patients E75 is a human leukocyte antigen-A2/A3-restricted immunogenic peptide derived from the HER2 protein. Investigators conducted phase I/II clinical trials vaccinating breast cancer patients with nelipepimut-S and GM-CSF in the adjuvant setting to prevent disease recurrence. [Ann Oncol] Abstract Significant Survival Impact of MACC1 Polymorphisms in HER2 Positive Breast Cancer Patients Researchers aimed to investigate the influence of metastasis-associated in colon cancer-1 (MACC1) polymorphisms on event-free and overall survival in patients with human epidermal growth factor 2 (HER2)-positive breast cancer. [Eur J Cancer] Abstract Heading to ISSCR 2014 in Vancouver? Come Visit Connexon Creative at Booth #507 and Enter to Win $100 Amazon Gift Card! |